ENDOGEN ApS: Financial statements 2013
CVR: 29813337
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 0 and a net result of DKK -14,190 compared with DKK -1,156 the year before. Equity amounted to DKK 106,914. The solvency ratio was 99.7%.
- Revenue
- 0 kr.
- Gross Profit
- -13,995 kr.
- Profit/Loss
- -14,190 kr.
- Equity
- 106,914 kr.
- Total Assets
- 107,247 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
Find more companies like ENDOGEN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
ENDOGEN ApS has published its annual report for 2012. Revenue came to DKK 0, and the net result was DKK -1,156.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.
